<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="/resources/spdi-openaccess-jats.xsl"?>
<!DOCTYPE response [
	
<!ENTITY % article SYSTEM "http://jats.nlm.nih.gov/archiving/1.2/JATS-archivearticle1.dtd">
<!ENTITY % book-part-wrapper SYSTEM "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
	]><response><apiMessage>This XML was provided by Springer Nature</apiMessage><query>doi:10.1186/s13756-019-0551-1</query><apiKey>6b19ee21fe6a243741a528650f7c8997</apiKey><result><total>1</total><start>1</start><pageLength>1</pageLength><recordsDisplayed>1</recordsDisplayed></result><records><article dtd-version="1.2" article-type="brief-report" xml:lang="en" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink"><?properties open_access?><front><journal-meta><journal-id journal-id-type="publisher-id">13756</journal-id><journal-title-group><journal-title>Antimicrobial Resistance &amp; Infection Control</journal-title><abbrev-journal-title abbrev-type="publisher">Antimicrob Resist Infect Control</abbrev-journal-title></journal-title-group><issn pub-type="epub">2047-2994</issn><publisher><publisher-name>BioMed Central</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">s13756-019-0551-1</article-id><article-id pub-id-type="manuscript">551</article-id><article-id pub-id-type="doi">10.1186/s13756-019-0551-1</article-id><article-categories><subj-group subj-group-type="heading"><subject>Short Report</subject></subj-group></article-categories><title-group><article-title xml:lang="en">CA-MRSA and HA-MRSA coexist in community and hospital settings in Uganda</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes" id="Au1"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-8075-3069</contrib-id><name><surname>Kateete</surname><given-names>David Patrick</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="corresp" rid="IDs1375601905511_cor1">a</xref></contrib><contrib contrib-type="author" id="Au2"><name><surname>Bwanga</surname><given-names>Freddie</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" id="Au3"><name><surname>Seni</surname><given-names>Jeremiah</given-names></name><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" id="Au4"><name><surname>Mayanja</surname><given-names>Raymond</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref><xref ref-type="aff" rid="Aff4">4</xref></contrib><contrib contrib-type="author" id="Au5"><name><surname>Kigozi</surname><given-names>Edgar</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" id="Au6"><name><surname>Mujuni</surname><given-names>Brian</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" id="Au7"><name><surname>Ashaba</surname><given-names>Fred K.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" id="Au8"><name><surname>Baluku</surname><given-names>Hannington</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" id="Au9"><name><surname>Najjuka</surname><given-names>Christine F.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" id="Au10"><name><surname>Källander</surname><given-names>Karin</given-names></name><xref ref-type="aff" rid="Aff5">5</xref><xref ref-type="aff" rid="Aff6">6</xref></contrib><contrib contrib-type="author" id="Au11"><name><surname>Rutebemberwa</surname><given-names>Elizeus</given-names></name><xref ref-type="aff" rid="Aff7">7</xref></contrib><contrib contrib-type="author" id="Au12"><name><surname>Asiimwe</surname><given-names>Benon B.</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" id="Au13"><name><surname>Joloba</surname><given-names>Moses L.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0620 0548</institution-id><institution-id institution-id-type="GRID">grid.11194.3c</institution-id><institution content-type="org-division">Department of Immunology and Molecular Biology</institution><institution content-type="org-name">Makerere University College of Health Sciences</institution></institution-wrap><addr-line content-type="city">Kampala</addr-line><country country="UG">Uganda</country></aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0620 0548</institution-id><institution-id institution-id-type="GRID">grid.11194.3c</institution-id><institution content-type="org-division">Department of Medical Microbiology</institution><institution content-type="org-name">Makerere University College of Health Sciences</institution></institution-wrap><addr-line content-type="city">Kampala</addr-line><country country="UG">Uganda</country></aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0451 3858</institution-id><institution-id institution-id-type="GRID">grid.411961.a</institution-id><institution content-type="org-name">Catholic University of Health and Allied Sciences – Bugando</institution></institution-wrap><addr-line content-type="city">Mwanza</addr-line><country country="TZ">Tanzania</country></aff><aff id="Aff4"><label>4</label><institution-wrap><institution-id institution-id-type="GRID">grid.452639.f</institution-id><institution content-type="org-name">Makerere University Walter Reed Project</institution></institution-wrap><addr-line content-type="city">Kampala</addr-line><country country="UG">Uganda</country></aff><aff id="Aff5"><label>5</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 6479 3388</institution-id><institution-id institution-id-type="GRID">grid.475304.1</institution-id><institution content-type="org-name">Malaria Consortium</institution></institution-wrap><addr-line content-type="city">London</addr-line><country country="GB">UK</country></aff><aff id="Aff6"><label>6</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 1937 0626</institution-id><institution-id institution-id-type="GRID">grid.4714.6</institution-id><institution content-type="org-division">Department of Public Health Sciences</institution><institution content-type="org-name">Karolinska Institutet</institution></institution-wrap><addr-line content-type="city">Stockholm</addr-line><country country="SE">Sweden</country></aff><aff id="Aff7"><label>7</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0004 0620 0548</institution-id><institution-id institution-id-type="GRID">grid.11194.3c</institution-id><institution content-type="org-name">Makerere University School of Public Health</institution></institution-wrap><addr-line content-type="city">Kampala</addr-line><country country="UG">Uganda</country></aff></contrib-group><author-notes><corresp id="IDs1375601905511_cor1"><label>a</label><email>dkateete@chs.mak.ac.ug</email></corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>3</day><month>6</month><year>2019</year></pub-date><pub-date date-type="collection" publication-format="electronic"><month>12</month><year>2019</year></pub-date><volume>8</volume><issue seq="93">1</issue><elocation-id>94</elocation-id><history><date date-type="registration"><day>29</day><month>5</month><year>2019</year></date><date date-type="received"><day>8</day><month>3</month><year>2019</year></date><date date-type="accepted"><day>28</day><month>5</month><year>2019</year></date><date date-type="online"><day>3</day><month>6</month><year>2019</year></date></history><permissions><copyright-statement>© The Author(s). 2019</copyright-statement><copyright-year>2019</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link xlink:href="http://creativecommons.org/licenses/by/4.0/" ext-link-type="url">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link xlink:href="http://creativecommons.org/publicdomain/zero/1.0/" ext-link-type="url">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><abstract id="Abs1" xml:lang="en"><title>Abstract</title><sec id="ASec1"><title>Background</title><p id="Par1">Methicillin resistant <italic>Staphylococcus aureus</italic> (MRSA) strains were once confined to hospitals however, in the last 20 years MRSA infections have emerged in the community in people with no prior exposure to hospitals. Strains causing such infections were novel and referred to as community-associated MRSA (CA-MRSA). The aim of this study was to determine the MRSA carriage rate in children in eastern Uganda, and to investigate coexistence between CA-MRSA and hospital-associated (HA-MRSA).</p></sec><sec id="ASec2"><title>Methods</title><p id="Par2">Between February and October 2011, nasopharyngeal samples (one per child) from 742 healthy children under 5 years in rural eastern Uganda were processed for isolation of MRSA, which was identified based on inhibition zone diameter of ≤19 mm on 30 μg cefoxitin disk. SCC<italic>mec</italic> and <italic>spa</italic> typing were performed for MRSA isolates.</p></sec><sec id="ASec3"><title>Results</title><p id="Par3">A total of 140 <italic>S. aureus</italic> isolates (18.9%, 140/742) were recovered from the children of which 5.7% (42/742) were MRSA. Almost all (95.2%, 40/42) MRSA isolates were multidrug resistant (MDR). The most prevalent SCC<italic>mec</italic> elements were types IV (40.5%, 17/42) and I (38.1%, 16/42). The overall frequency of SCC<italic>mec</italic> types IV and V combined, hence CA-MRSA, was 50% (21/42). Likewise, the overall frequency of SCC<italic>mec</italic> types I, II and III combined, hence HA-MRSA, was 50% (21/42). Spa types t002, t037, t064, t4353 and t12939 were detected and the most frequent were t064 (19%, 8/42) and t037 (12%, 5/42).</p></sec><sec id="ASec4"><title>Conclusion</title><p id="Par4">The MRSA carriage rate in children in eastern Uganda is high (5.7%) and comparable to estimates for Mulago Hospital in Kampala city. Importantly, HA-MRSA (mainly of <italic>spa</italic> type t037) and CA-MRSA (mainly of <italic>spa</italic> type t064) coexist in children in the community in eastern Uganda, and due to high proportion of MDR detected, outpatient treatment of MRSA infection in eastern Uganda might be difficult.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Eastern Uganda</kwd><kwd>Iganga/Mayuge districts</kwd><kwd>Coexistence</kwd><kwd>Hospital-associated MRSA</kwd><kwd>Community-associated MRSA</kwd><kwd><italic>mecA</italic></kwd><kwd>SCC<italic>mec</italic> types</kwd><kwd><italic>spa</italic> types</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>publisher-imprint-name</meta-name><meta-value>BioMed Central</meta-value></custom-meta><custom-meta><meta-name>volume-issue-count</meta-name><meta-value>1</meta-value></custom-meta><custom-meta><meta-name>issue-article-count</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>issue-toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>issue-pricelist-year</meta-name><meta-value>2019</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-holder</meta-name><meta-value>The Author(s)</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-year</meta-name><meta-value>2019</meta-value></custom-meta><custom-meta><meta-name>article-contains-esm</meta-name><meta-value>Yes</meta-value></custom-meta><custom-meta><meta-name>article-numbering-style</meta-name><meta-value>Unnumbered</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-year</meta-name><meta-value>2019</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-month</meta-name><meta-value>5</meta-value></custom-meta><custom-meta><meta-name>article-registration-date-day</meta-name><meta-value>29</meta-value></custom-meta><custom-meta><meta-name>article-toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>toc-levels</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>volume-type</meta-name><meta-value>Regular</meta-value></custom-meta><custom-meta><meta-name>journal-product</meta-name><meta-value>ArchiveJournal</meta-value></custom-meta><custom-meta><meta-name>numbering-style</meta-name><meta-value>Unnumbered</meta-value></custom-meta><custom-meta><meta-name>article-grants-type</meta-name><meta-value>OpenChoice</meta-value></custom-meta><custom-meta><meta-name>metadata-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>abstract-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bodypdf-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bodyhtml-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>bibliography-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>esm-grant</meta-name><meta-value>OpenAccess</meta-value></custom-meta><custom-meta><meta-name>online-first</meta-name><meta-value>false</meta-value></custom-meta><custom-meta><meta-name>pdf-file-reference</meta-name><meta-value>BodyRef/PDF/13756_2019_Article_551.pdf</meta-value></custom-meta><custom-meta><meta-name>pdf-type</meta-name><meta-value>Typeset</meta-value></custom-meta><custom-meta><meta-name>target-type</meta-name><meta-value>OnlinePDF</meta-value></custom-meta><custom-meta><meta-name>issue-type</meta-name><meta-value>Regular</meta-value></custom-meta><custom-meta><meta-name>article-type</meta-name><meta-value>BriefCommunication</meta-value></custom-meta><custom-meta><meta-name>journal-subject-primary</meta-name><meta-value>Biomedicine</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Medical Microbiology</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Drug Resistance</meta-value></custom-meta><custom-meta><meta-name>journal-subject-secondary</meta-name><meta-value>Infectious Diseases</meta-value></custom-meta><custom-meta><meta-name>journal-subject-collection</meta-name><meta-value>Biomedical and Life Sciences</meta-value></custom-meta><custom-meta><meta-name>open-access</meta-name><meta-value>true</meta-value></custom-meta></custom-meta-group></article-meta><notes notes-type="ESMHint"><title>Electronic supplementary material</title><p>The online version of this article (<ext-link xlink:href="https://doi.org/10.1186/s13756-019-0551-1" ext-link-type="doi">https://doi.org/10.1186/s13756-019-0551-1</ext-link>) contains supplementary material, which is available to authorized users.</p></notes></front><body><sec id="Sec1"><title>Background</title><p id="Par16"><italic>Staphylococcus aureus</italic> is a recognized cause of mild to severe infections worldwide [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. However, the burden due to staphylococcal infections in Africa is apparently overshadowed by the ‘big three’ diseases –HIV/AIDS, tuberculosis and malaria [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>]. Indeed, surveillance studies on bacterial infections in Africa show that <italic>S. aureus</italic> is a common pathogen in healthy adults and immunosuppressed individuals [<xref ref-type="bibr" rid="CR3">3</xref>–<xref ref-type="bibr" rid="CR12">12</xref>], and persons with genetic predispositions [<xref ref-type="bibr" rid="CR10">10</xref>]. As well, <italic>S. aureus</italic> is second only to the pneumococcus among the frequent causes of pneumonia in children in Africa [<xref ref-type="bibr" rid="CR13">13</xref>].</p><p id="Par17">Methicillin resistant <italic>S. aureus</italic> (MRSA) strains, now widespread globally, have complicated treatment and control of staphylococcal infections. Once confined to hospitals and/or health care environments, MRSA strains are now frequent causes of infection in the community. Nevertheless, surveillance studies have revealed differences in MRSA strains causing infections in hospitalized patients and healthcare workers in hospitals vis-à-vis MRSA isolates causing infection in the community (i.e. community-associated MRSA) [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR14">14</xref>]. While such demarcation of MRSA as “hospital/health care-associated MRSA” (HA-MRSA) or “community-associated MRSA” (CA-MRSA) can be confusing [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR14">14</xref>–<xref ref-type="bibr" rid="CR16">16</xref>], there are clear differences in phenotypes and genetic background of MRSA strains associated with infection in either setting, community or hospital [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR18">18</xref>]. Genotypically, CA-MRSA are newer and more virulent strains, which emerged in the late 1990s as major causes of skin and soft tissue infections in healthy and relatively young people with no prior exposure to hospitals [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR20">20</xref>]. CA-MRSA strains typically carry SCC<italic>mec</italic> types IV or V and they are generally susceptible to non-β-lactam antimicrobials [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR14">14</xref>]. Additionally, CA-MRSA carry (but not always) Panton Valentine Leukocidin (PVL) encoding genes <italic>LukS-PV</italic> and <italic>LukF-PV</italic> [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>] that are associated with increased virulence. On the other hand, HA-MRSA strains carry SCC<italic>mec</italic> types I, II, or III and seldom possess PVL-encoding genes [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. HA-MRSA are associated with nosocomial infections e.g. endocarditis and they are often resistant to non-β-lactam antimicrobial agents especially aminoglycosides, macrolides, lincosamides and fluoroquinolones [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>].</p><p id="Par18">Although CA-MRSA has been predicted to replace HA-MRSA in hospitals [<xref ref-type="bibr" rid="CR19">19</xref>], mathematical models predict coexistence between the two strains given the high rates of discharge and hospitalization which bolster hospital-community interactions [<xref ref-type="bibr" rid="CR21">21</xref>]. Relatedly, we previously detected MRSA strains carrying SCC<italic>mec</italic> types IV or V at Mulago Hospital in Kampala city [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>], pointing to coexistence between CA-MRSA and HA-MRSA in the hospital. The aim of this study was to determine the MRSA carriage rate in children in eastern Uganda, and to investigate coexistence between CA-MRSA and HA-MRSA.</p></sec><sec id="Sec2" sec-type="methods"><title>Methods</title><sec id="Sec3"><title>Study setting, susceptibility testing and MRSA identification</title><p id="Par19">This cross-sectional study was nested in a study that investigated pneumococcal carriage in children under 5 years age in the Iganga/Mayuge Health &amp; Demographic Surveillance Site (IMHDSS) [<xref ref-type="bibr" rid="CR13">13</xref>], located in Iganga and Mayuge districts in eastern Uganda 120 km from Kampala city, Uganda’s capital. The IMHDSS is a rural community covering a contiguous area of ~ 155 km<sup>2</sup> comprising of 65 villages and approx. 85,000 people living in 15,652 households. It is characterized with significant interaction between healthcare workers and community members, and 13% of its population are children under 5 years of age [<xref ref-type="bibr" rid="CR24">24</xref>].</p><p id="Par20">The children screened for MRSA carriage were from a total of 742 households (one child per household). They were selected from the IMHDSS population register using simple random sampling. Each household was visited and a child aged between 2 months and 59 months was selected using the lottery method of sampling. Using a pretested questionnaire, the primary caretaker of the child in each household was interviewed for information on demographic characteristics, history of illnesses and antibiotic treatment. Following caretaker consent, a nasopharyngeal sample from each child was collected by a study nurse using pre-packed sterile calcium alginate swabs on flexible aluminum shafts (Becton, Dickson and Company, New Jersey). Swabs were placed in Amies transport medium in a tube and transported to the Clinical Microbiology laboratory at Makerere University College of Health Sciences where they were processed for culturing and isolation/identification of <italic>S. aureus</italic> according to standard microbiological procedures published previously [<xref ref-type="bibr" rid="CR25">25</xref>].</p><p id="Par21">Susceptibility of <italic>S. aureus</italic> to antibiotics was determined by the disc diffusion antibiotic sensitivity testing method as recommended by the Clinical and Laboratory Standards Institute, (CLSI, 2011) [<xref ref-type="bibr" rid="CR26">26</xref>]. Briefly, colonies of pure bacterial isolates were suspended in sterile normal saline to a turbidity of McFarland standard 0.5, and uniformly spread on Muller Hinton agar (MHA) plates (Biolabs®, Hungary) with antibiotic disks (Biolabs®, Hungary): penicillin G (10 U), cefoxitin (30 μg), clindamycin (2 μg), erythromycin (15 μg), vancomycin (30 μg), tetracycline (30 μg), linezolid (30 μg), trimethoprim/sulphamethoxazole (1.25/23.5 μg), chloramphenicol (5 μg), ciprofloxacin (5 μg), and gentamicin (10 μg). Plates were incubated at 37 °C for 24 h. Inhibition zones were measured in millimeters and interpreted as susceptible (S), intermediate (I) or resistant (R). <italic>S. aureus</italic> with inhibition zone diameters of ≤19 mm on 30 μg cefoxitin disk were considered to be MRSA, and confirmed for <italic>mecA</italic> gene carriage by PCR [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR22">22</xref>].</p></sec><sec id="Sec4"><title>Classification of isolates as CA-MRSA or HA-MRSA</title><p id="Par22">Because CA-MRSA and HA-MRSA can be recovered from either setting (i.e. community or hospital), to classify isolates as CA-MRSA or HA-MRSA we used isolate genotypic characteristics and not clinical/epidemiological features. Thus, given that SCC<italic>mec</italic> types I, II &amp; III are typically restricted to HA-MRSA and not found widely in healthy populations while SCC<italic>mec</italic> types IV &amp; V are predominantly associated with CA-MRSA [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR27">27</xref>], MRSA isolates that carried SCC<italic>mec</italic> types I, II, or III were classified as HA-MRSA while isolates with SCC<italic>mec</italic> types IV or V were classified as CA-MRSA [<xref ref-type="bibr" rid="CR28">28</xref>]. SCC<italic>mec</italic> genotyping to delineate HA-MRSA and CA-MRSA was performed as described by Boye, et al., (2007) [<xref ref-type="bibr" rid="CR29">29</xref>]. Also, we compared SCC<italic>mec</italic> types for MRSA isolates from the IMHDSS in eastern Uganda to previously described SCC<italic>mec</italic> types for MRSA isolates from Mulago Hospital in Kampala [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>] and pastoral communities in rural western Uganda [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>]. Coexistence between HA-MRSA and CA-MRSA in the community or hospital was based on occurrence of MRSA strains with genetic background of both HA-MRSA (i.e. SCC<italic>mec</italic> types I, II or III) and CA-MRSA (i.e. SCC<italic>mec</italic> types IV or V) in either setting.</p></sec><sec id="Sec5"><title>Spa typing</title><p id="Par23">For spa typing, the <italic>x</italic>-region (200–400 bp) of <italic>S. aureus spa</italic> gene was amplified from MRSA with primers and PCR conditions described by Harmsen et al., 2003 [<xref ref-type="bibr" rid="CR32">32</xref>]. Purified PCR products were sequenced at MBN Laboratories (Kampala, Uganda) or ACGT Inc. (Wheeling, IL, USA) using forward and reverse primers used in PCRs. To obtain <italic>spa</italic> types, sequences were submitted to an online spaTyper server (<ext-link xlink:href="http://spatyper.fortinbras.us/" ext-link-type="url">http://spatyper.fortinbras.us/</ext-link>) and confirmed by cross-checking with Ridom Spa Server (<ext-link xlink:href="http://spaserver2.ridom.de/spatypes.shtml" ext-link-type="url">http://spaserver2.ridom.de/spatypes.shtml</ext-link>). For quality control, standard reference <italic>S. aureus</italic> strains ATCC-43300 -<italic>mecA</italic>+, PVL- (MRSA) and ATCC-29213 -mecA-, PVL- (MSSA) &amp; ATCC-25923 -<italic>mecA</italic>-, PVL+ (MSSA) were used as positive or negative controls. Furthermore, to detect <italic>PVL</italic> genes, isolates were subjected to PCR-detection of a 433 bp fragment overlapping the <italic>lukS-PV</italic> and <italic>lukF-PV</italic> genes using previously published protocols [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>]. Apart from <italic>spa</italic> typing in which all PCR products were sequenced, DNA sequencing of amplified segments of <italic>mecA</italic> and <italic>PVL</italic> genes for randomly selected isolates was performed and sequences confirmed by BLAST searching at the National Center for Biotechnology Information (NCBI) <ext-link xlink:href="https://blast.ncbi.nlm.nih.gov/Blast.cgi" ext-link-type="url">https://blast.ncbi.nlm.nih.gov/Blast.cgi</ext-link></p></sec></sec><sec id="Sec6" sec-type="results"><title>Results</title><sec id="Sec7"><title>Demographics</title><p id="Par24">MRSA isolates were recovered from 42 of the 742 children sampled. The characteristics of study population were described previously [<xref ref-type="bibr" rid="CR13">13</xref>] however, we will highlight a few statistics pertinent to this study. The mean age of the children was 30 months and 52% were girls. All children were healthy at the time of screening i.e. none had observable clinical symptoms however, based on reports of caretakers (mothers), majority (≥90%) were sick 2 weeks prior to screening and the most common symptoms were fever, running nose and cough. Approx. 30% of the previously sick children were given antibiotics, mostly ampicillin and co-trimoxazole.</p></sec><sec id="Sec8"><title>MRSA prevalence and drug resistance patterns</title><p id="Par25">The processed nasopharyngeal samples yielded 600 Gram positive and catalase positive isolates (one per sample/child) of which 140 were confirmed to be <italic>S. aureus</italic>. Thirty per cent (42/140) of <italic>S. aureus</italic> were cefoxitin resistant and these were confirmed to be MRSA upon <italic>mecA</italic> gene PCR (all 42 isolates were <italic>mecA</italic> positive). Thus, MRSA prevalence in <italic>S. aureus</italic> isolates was 30% and its carriage rate in children was 5.7% (42/742). Almost all MRSA isolates i.e. 95.2% (40/42) were multidrug resistant (MDR, resistance to three or more classes of antimicrobials) and MDR rates for CA-MRSA and HA-MRSA isolates were similar, Table <xref rid="Tab1" ref-type="table">1</xref>. All MRSA isolates were susceptible to rifampicin and anti-MRSA agents (vancomycin &amp; linezolid) and generally to clindamycin but they were significantly resistant to non-β-lactam antimicrobial agents commonly used to treat staphylococcal infections (SXT, erythromycin, gentamicin, chloramphenicol).<table-wrap id="Tab1"><label>Table 1</label><caption xml:lang="en"><p>Genotypes and antibiotic susceptibility patterns of CA- &amp; HA-MRSA from children ≤5 years in eastern Uganda</p></caption><table frame="hsides" rules="groups"><thead><tr><th><p>Isolate #</p></th><th><p>PVL</p></th><th><p><italic>mecA</italic></p></th><th><p>SCC<italic>mec</italic></p></th><th><p>FOX</p></th><th><p>PEN</p></th><th><p>TET</p></th><th><p>ERY</p></th><th><p>SXT</p></th><th><p>CHL</p></th><th><p>GEN</p></th><th><p>CIP</p></th><th><p>CLI</p></th><th><p>RIF</p></th><th><p>VAN</p></th><th><p>LZD</p></th><th><p>MDR phenotype</p></th><th><p><italic>Spa</italic> type</p></th></tr></thead><tbody><tr><td colspan="18"><p>HA-MRSA (<italic>n</italic> = 21)</p></td></tr><tr><td><p> 52–1</p></td><td><p>+</p></td><td><p>+</p></td><td><p>I</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>Yes</p></td><td/></tr><tr><td><p> 1320–1</p></td><td><p>–</p></td><td><p>+</p></td><td><p>I</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>Yes</p></td><td/></tr><tr><td><p> 244C-1</p></td><td><p>–</p></td><td><p>+</p></td><td><p>I</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>Yes</p></td><td/></tr><tr><td><p> K1057–1</p></td><td><p>–</p></td><td><p>+</p></td><td><p>I</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>S</p></td><td><p>S</p></td><td><p>R</p></td><td><p>R</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>Yes</p></td><td><p><bold>t037</bold></p></td></tr><tr><td><p> K264–1</p></td><td><p>+</p></td><td><p>+</p></td><td><p>I</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>S</p></td><td><p>S</p></td><td><p>R</p></td><td><p>R</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>Yes</p></td><td/></tr><tr><td><p> K284–1</p></td><td><p>–</p></td><td><p>+</p></td><td><p>I</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>Yes</p></td><td/></tr><tr><td><p> K36–1</p></td><td><p>–</p></td><td><p>+</p></td><td><p>I</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>Yes</p></td><td><p><bold>t037</bold></p></td></tr><tr><td><p> K370–1</p></td><td><p>–</p></td><td><p>+</p></td><td><p>I</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>Yes</p></td><td/></tr><tr><td><p> K39–1</p></td><td><p>–</p></td><td><p>+</p></td><td><p>I</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>Yes</p></td><td/></tr><tr><td><p> K4834–1</p></td><td><p>–</p></td><td><p>+</p></td><td><p>I</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>S</p></td><td><p>S</p></td><td><p>R</p></td><td><p>R</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>Yes</p></td><td><p><bold>t037</bold></p></td></tr><tr><td><p> K970–1</p></td><td><p>–</p></td><td><p>+</p></td><td><p>I</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>S</p></td><td><p>I</p></td><td><p>S</p></td><td><p>S</p></td><td><p>I</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>No</p></td><td><p><bold>t037</bold></p></td></tr><tr><td><p> R030–1</p></td><td><p>–</p></td><td><p>+</p></td><td><p>I</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>Yes</p></td><td/></tr><tr><td><p> R10–1</p></td><td><p>–</p></td><td><p>+</p></td><td><p>I</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>S</p></td><td><p>R</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>Yes</p></td><td><p>t12939</p></td></tr><tr><td><p> R110–1</p></td><td><p>+</p></td><td><p>+</p></td><td><p>I</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>Yes</p></td><td><p>Unknown</p></td></tr><tr><td><p> R19–1</p></td><td><p>–</p></td><td><p>+</p></td><td><p>I</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>Yes</p></td><td/></tr><tr><td><p> R220–1</p></td><td><p>–</p></td><td><p>+</p></td><td><p>I</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>S</p></td><td><p>R</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>Yes</p></td><td><p>Unknown</p></td></tr><tr><td><p> 1322–1</p></td><td><p>+</p></td><td><p>+</p></td><td><p>II</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>I</p></td><td><p>I</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>Yes</p></td><td/></tr><tr><td><p> 306C-1</p></td><td><p>–</p></td><td><p>+</p></td><td><p>II</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>I</p></td><td><p>R</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>Yes</p></td><td/></tr><tr><td><p> K911–1</p></td><td><p>–</p></td><td><p>+</p></td><td><p>II</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>S</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>Yes</p></td><td/></tr><tr><td><p> R160–1</p></td><td><p>–</p></td><td><p>+</p></td><td><p>II</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>Yes</p></td><td><p>t002</p></td></tr><tr><td><p> R17–1</p></td><td><p>–</p></td><td><p>+</p></td><td><p>III</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>S</p></td><td><p>R</p></td><td><p>S</p></td><td><p>I</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>Yes</p></td><td><p><bold>t037</bold></p></td></tr><tr><td><p> Total +/R HA-MRSA (%)</p></td><td><p>4 (19)</p></td><td><p>21 (100)</p></td><td><p>21 (100)</p></td><td><p>21 (100)</p></td><td><p>21 (100)</p></td><td><p>21 (100)</p></td><td><p>16 (76.2)</p></td><td><p>16 (76.2)</p></td><td><p>15 (71.4)</p></td><td><p>15 (71.4)</p></td><td><p>5 (23.8)</p></td><td><p>0 (0)</p></td><td><p>0 (0)</p></td><td><p>0 (0)</p></td><td><p>0 (0)</p></td><td><p>20 (95.2)</p></td><td/></tr><tr><td colspan="18"><p>CA-MRSA (<italic>n</italic> = 21)</p></td></tr><tr><td><p> 1325–1</p></td><td><p>–</p></td><td><p>+</p></td><td><p>IV</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>I</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>Yes</p></td><td><p>Unknown</p></td></tr><tr><td><p> 1326–1</p></td><td><p>+</p></td><td><p>+</p></td><td><p>IV</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>R</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>Yes</p></td><td/></tr><tr><td><p> K2240–1</p></td><td><p>–</p></td><td><p>+</p></td><td><p>IV</p></td><td><p>R</p></td><td><p>R</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>R</p></td><td><p>I</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>No</p></td><td><p>t4353</p></td></tr><tr><td><p> K2810–1</p></td><td><p>–</p></td><td><p>+</p></td><td><p>IV</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>S</p></td><td><p>S</p></td><td><p>R</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>Yes</p></td><td/></tr><tr><td><p> R31B-1</p></td><td><p>–</p></td><td><p>+</p></td><td><p>IV</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>S</p></td><td><p>R</p></td><td><p>R</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>Yes</p></td><td><p><bold>t064</bold></p></td></tr><tr><td><p> R310–1</p></td><td><p>–</p></td><td><p>+</p></td><td><p>IV</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>Yes</p></td><td><p><bold>t064</bold></p></td></tr><tr><td><p> R33–1</p></td><td><p>+</p></td><td><p>+</p></td><td><p>IV</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>Yes</p></td><td><p><bold>t064</bold></p></td></tr><tr><td><p> K3700–1</p></td><td><p>–</p></td><td><p>+</p></td><td><p>IV</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>S</p></td><td><p>S</p></td><td><p>R</p></td><td><p>R</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>Yes</p></td><td/></tr><tr><td><p> R0100–1</p></td><td><p>–</p></td><td><p>+</p></td><td><p>IV</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>Yes</p></td><td><p><bold>t064</bold></p></td></tr><tr><td><p> R02–1</p></td><td><p>–</p></td><td><p>+</p></td><td><p>IV</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>S</p></td><td><p>R</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>Yes</p></td><td><p>Unknown</p></td></tr><tr><td><p> R020–1</p></td><td><p>–</p></td><td><p>+</p></td><td><p>IV</p></td><td><p>R</p></td><td><p>R</p></td><td><p>S</p></td><td><p>S</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>Yes</p></td><td/></tr><tr><td><p> R0300–1</p></td><td><p>–</p></td><td><p>+</p></td><td><p>IV</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>Yes</p></td><td/></tr><tr><td><p> R06–1</p></td><td><p>–</p></td><td><p>+</p></td><td><p>IV</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>S</p></td><td><p>R</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>Yes</p></td><td><p><bold>t064</bold></p></td></tr><tr><td><p> R08–1</p></td><td><p>+</p></td><td><p>+</p></td><td><p>IV</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>Yes</p></td><td><p><bold>t064</bold></p></td></tr><tr><td><p> R18–1</p></td><td><p>–</p></td><td><p>+</p></td><td><p>IV</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>S</p></td><td><p>R</p></td><td><p>S</p></td><td><p>R</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>Yes</p></td><td/></tr><tr><td><p> R20–1</p></td><td><p>–</p></td><td><p>+</p></td><td><p>IV</p></td><td><p>R</p></td><td><p>R</p></td><td><p>I</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>Yes</p></td><td><p><bold>t064</bold></p></td></tr><tr><td><p> R26A-1</p></td><td><p>–</p></td><td><p>+</p></td><td><p>IV</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>S</p></td><td><p>S</p></td><td><p>R</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>Yes</p></td><td><p><bold>t064</bold></p></td></tr><tr><td><p> R040–1</p></td><td><p>–</p></td><td><p>+</p></td><td><p>V</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>Yes</p></td><td/></tr><tr><td><p> K60–1</p></td><td><p>+</p></td><td><p>+</p></td><td><p>V</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>S</p></td><td><p>S</p></td><td><p>R</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>Yes</p></td><td/></tr><tr><td><p> K38–1</p></td><td><p>–</p></td><td><p>+</p></td><td><p>V</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>I</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>Yes</p></td><td/></tr><tr><td><p> K350C-1</p></td><td><p>+</p></td><td><p>+</p></td><td><p>V</p></td><td><p>R</p></td><td><p>R</p></td><td><p>R</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>R</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>S</p></td><td><p>Yes</p></td><td><p>Unknown</p></td></tr><tr><td><p> Total +/R CA-MRSA (%)</p></td><td><p>5 (24)</p></td><td><p>21 (100)</p></td><td><p>21 (100)</p></td><td><p>21 (100)</p></td><td><p>21 (100)</p></td><td><p>18 (85.7)</p></td><td><p>17 (81)</p></td><td><p>16 (76.2)</p></td><td><p>12 (57.1)</p></td><td><p>10 (47.6)</p></td><td><p>10 (47.6)</p></td><td><p>0 (0)</p></td><td><p>0 (0)</p></td><td><p>0 (0)</p></td><td><p>0 (0)</p></td><td><p>20 (95.2)</p></td><td/></tr><tr><td><p><bold>Grand Total +/R (%)</bold></p></td><td><p><bold>9 (21.4)</bold></p></td><td><p>42 (100)</p></td><td><p>42 (100)</p></td><td><p><bold>42 (100)</bold></p></td><td><p><bold>42 (100)</bold></p></td><td><p><bold>39 (92.9)</bold></p></td><td><p><bold>33 (78.6)</bold></p></td><td><p><bold>32 (76.2)</bold></p></td><td><p><bold>27 (64.3)</bold></p></td><td><p><bold>25 (59.5)</bold></p></td><td><p><bold>15 (35.7)</bold></p></td><td><p><bold>0 (0)</bold></p></td><td><p><bold>0 (0)</bold></p></td><td><p><bold>0 (0)</bold></p></td><td><p><bold>0 (0)</bold></p></td><td><p><bold>40/42 (95.2)</bold></p></td><td/></tr></tbody></table><table-wrap-foot><p>The most prevalent Spa types are presented in boldface font</p><p><italic>FOX</italic> cefoxitin, <italic>PEN</italic> penicillin, <italic>TET</italic> tetracycline, <italic>SXT</italic>, <italic>ERY</italic> erythromycin, <italic>CHL</italic> chloramphenicol, <italic>GEN</italic> gentamycin, <italic>CIP</italic> ciprofloxacin, <italic>CLI</italic> clindamycin, <italic>RIF</italic> rifampicin, <italic>VAN</italic> vancomycin, <italic>LZD</italic> linezolid, <italic>MDR</italic> multidrug resistant –resistance to three or more classes of antimicrobials; <italic>+</italic> Positive, − Negative</p></table-wrap-foot></table-wrap></p></sec><sec id="Sec9"><title>Spa types and SCC<italic>mec</italic> elements</title><p id="Par26">The most predominant SCC<italic>mec</italic> elements were SCC<italic>mec</italic> type IV (40.5%, 17/42) and SCC<italic>mec</italic> type I (38.1%, 16/42). SCC<italic>mec</italic> types II and V accounted for 4 isolates each (9.5%, 4/42) while SCC<italic>mec</italic> type III accounted for one isolate. The overall frequency of SCC<italic>mec</italic> types IV and V combined, which define the genetic background of MRSA isolates associated with the community, was 50% (21/42) implying the prevalence of CA-MRSA in children was 50% (21/42). This is relatively low compared to reported rates of CA-MRSA in the community. Furthermore, the overall frequency of SCC<italic>mec</italic> types I, II and III combined, which define the genetic trait of MRSA isolates associated with healthcare environments, was 50% (21/42) hence similar to SCC<italic>mec</italic> types IV and IV combined. The <italic>PVL</italic> gene prevalence was low (i.e. 21.4%, 9/42) and distributed equally in CA-MRSA and HA-MRSA, Table <xref rid="Tab1" ref-type="table">1</xref>. Taken together, these data show that CA-MRSA and HA-MRSA coexist in children in the community in eastern Uganda, Table <xref rid="Tab1" ref-type="table">1</xref> &amp; Fig. <xref rid="Fig1" ref-type="fig">1</xref>.<fig id="Fig1"><label>Fig. 1</label><caption xml:lang="en"><p>SCCmec types for MRSA isolates depicting coexistence between CA-MRSA and HA-MRSA in children under 5 years in rural eastern Uganda. Note that the categorization of MRSA isolates as CA-MRSA or HA-MRSA is based on their genetic background (i.e. SCC<italic>mec</italic> types) and not clinical/epidemiological associations. MH denotes Mulago National Referral Hospital; IMHDSS, Health &amp; Demographic Surveillance Site; RWU, Rural Western Uganda</p></caption><p><graphic specific-use="HTML" mime-subtype="PNG" xlink:href="MediaObjects/13756_2019_551_Fig1_HTML.png" id="MO1"/></p></fig></p><p id="Par27">The observed coexistence between CA-MRSA and HA-MRSA in Uganda was first reported at Mulago Hospital in Kampala [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>] but not explored further. Therefore, we compared previously reported SCC<italic>mec</italic> types for isolates at Mulago Hospital [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>] and pastoral communities in western Uganda [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>] with SCC<italic>mec</italic> types for isolates from IMHDSS. Due to frequent interactions between healthcare personnel from the Mulago Hospital setting and community members in IMHDSS, we hypothesized that the SCC<italic>mec</italic> types’ distribution in the two settings would be similar. Indeed, there was no statistical significance (<italic>P</italic> = 0.1014) in the distribution of SCC<italic>mec</italic> types between the IMHSS and Mulago Hospital (Fig. <xref rid="Fig1" ref-type="fig">1</xref>) hence, CA-MRSA and HA-MRSA coexist in IMHDSS (community) and Mulago Hospital. Conversely, MRSA from pastoral communities in rural western Uganda carried only SCC<italic>mec</italic> types IV and V, Fig. <xref rid="Fig1" ref-type="fig">1</xref>.</p><p id="Par28">A total of five genotypes (t002, t037, t064, t4353 and t12939) were detected among MRSA and the most predominant were t064 (19%, 8/42) and t037 (12%, 5/42). Thus, t064 and t037 are the prevalent spa types among CA-MRSA and HA-MRSA isolates respectively, Table <xref rid="Tab1" ref-type="table">1</xref> &amp; Additional file <xref ref-type="supplementary-material" rid="MOESM1">1</xref>: Figure S1. When we compared <italic>spa</italic> types with MRSA isolates from Mulago Hospital [<xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>] and pastoral communities in rural western Uganda [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>], we found that with the exception of t002 and t12939, spa types for MRSA isolates from IMHDSS were previously reported, Additional file <xref ref-type="supplementary-material" rid="MOESM1">1</xref>: Figure S1. There were subtle differences in distribution of <italic>spa</italic> types with respect to setting e.g. <italic>spa</italic> types restricted to pastoral communities in rural western Uganda (circled in Additional file <xref ref-type="supplementary-material" rid="MOESM1">1</xref>: Figure S1).</p></sec></sec><sec id="Sec10" sec-type="discussion"><title>Discussion</title><p id="Par29">In this study, we found the MRSA carriage rate (5.7%) in children in eastern Uganda to be high and comparable to reported estimates for MRSA prevalence in adult populations in Uganda [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR23">23</xref>] and generally East Africa [<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR34">34</xref>]. Furthermore, we have shown that CA-MRSA and HA-MRSA strains coexist in the community in eastern Uganda and at Mulago hospital in Kampala city. Coexistence between CA-MRSA and HA-MRSA has been reported extensively in developed countries [<xref ref-type="bibr" rid="CR16">16</xref>, <xref ref-type="bibr" rid="CR35">35</xref>–<xref ref-type="bibr" rid="CR38">38</xref>] and beyond [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR39">39</xref>–<xref ref-type="bibr" rid="CR42">42</xref>] but few studies in Africa have explored it. Note, the terms ‘CA-MRSA’ and ‘HA-MRSA’ have also been used to describe the epidemiological and clinical features of MRSA e.g. the CDC case definition for CA-MRSA infection “Any MRSA infection diagnosed for an outpatient or within 48 h of hospitalization if the patient lacks the following health care-associated MRSA risk factors: hemodialysis, surgery, residence in a long-term care facility or hospitalization during the previous year, the presence of an indwelling catheter or a percutaneous device at the time of culture” [<xref ref-type="bibr" rid="CR1">1</xref>], but such epidemiological/clinical definitions are also misleading [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR21">21</xref>]. While there is no consensus on interpretation of ‘HA-MRSA vs. CA-MRSA’, MRSA strains are genotypically distinguishable through a simple PCR assay, SCCmec typing. Currently there are nine SCC<italic>mec</italic> types –I, II, III, IVa, IVb, V, VI, VII, VIII and V<sub>T</sub> [<xref ref-type="bibr" rid="CR1">1</xref>]; types I, II and III are large and occur in HA-MRSA strains while types IV and V are smaller and occur in CA-MRSA strains [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR21">21</xref>].</p><p id="Par30">There are several factors that could be fuelling coexistence between CA-MRSA and HA-MRSA in the community in eastern Uganda. First, previous exposure to antibiotics and/or health care facilities as the children were reported to be previously sick. The mothers reported that about one third of the children had been given ampicillin and co-trimoxazole and this could explain the high prevalence of MRSA and SXT resistance detected. It is important to note that over-treatment of children with antibiotics is common in Uganda as children suffer from 0.3 episodes of pneumonia every year [<xref ref-type="bibr" rid="CR13">13</xref>]. Also, Uganda adopted the World Health Organization’s (WHO) integrated case management of childhood illnesses under which community health workers provide prompt treatment of malaria and bacterial infections for children less than 5 years of age. The WHO’s integrated case management guidelines are based on simple clinical signs to help health workers identify and manage malaria, pneumonia and other childhood illnesses in the community. Although they have been found to increase rational prescription of medicines, the WHO guidelines do not distinguish between viral, parasitic (excluding plasmodium) and bacterial infections implying that a significant number of children in the community receive antibiotics [<xref ref-type="bibr" rid="CR13">13</xref>]. Thus, some MRSA strains in IMHDSS were indeed HA-MRSA perhaps arising from circulation of “escaped”/“feral” HA-MRSA strains in the community as a consequence of management of childhood infections at home [<xref ref-type="bibr" rid="CR1">1</xref>].</p><p id="Par31">The second factor underlying coexistence of CA-MRSA and HA-MRSA in children in eastern Uganda and generally at Mulago Hospital could be the interaction between healthcare workers and community members. Mathematical models of MRSA transmission have predicted that Hospital-Community interactions foster coexistence between CA-MRSA and HA-MRSA strains as the high discharge and hospitalization rates continuously cycle individuals between hospitals and the community [<xref ref-type="bibr" rid="CR21">21</xref>]. Besides, other investigators have implicated frequent interaction between healthcare workers and community members in increasing the risk of colonization with MRSA in the community [<xref ref-type="bibr" rid="CR17">17</xref>]. In Uganda, medical students, faculty, health care workers and researchers from the Mulago Hospital setting which includes Makerere University medical school use the IMHDSS as a site for disease surveillance, research and community-based medical education. The IMHDSS community members could also be colonized by HA-MRSA from nearby healthcare facilities as the IMHDSS is served by a government hospital, nine public health centers, three non-governmental organization hospitals, 122 drug shops and private clinics [<xref ref-type="bibr" rid="CR24">24</xref>]. Furthermore, studies by Asiimwe et al. [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>] on MRSA carriage in pastoral communities in rural western Uganda provided additional support for coexistence between CA-MRSA and HA-MRSA in the IMHDSS and Mulago Hospital. MRSA isolates from pastoral communities in rural western Uganda carried only SCC<italic>mec</italic> types IV and V that are typical of CA-MRSA and SCC<italic>mec</italic> types I, II and III were not detected [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>] hence, CA-MRSA and HA-MRSA do not coexist in pastoral communities in rural western Uganda. In context of health service delivery in Uganda, this is understandable as pastoral communities are remote and often characterized with inadequate health service delivery.</p><p id="Par32">Almost all MRSA isolates in this study were MDR. As HA-MRSA strains are associated with multiple resistance to non-β-lactam antimicrobial agents, perhaps their prevalence contributed to the observed high resistance to non-β-lactam antimicrobials. On the other hand, CA-MRSA strains are usually susceptible to non-β-lactam antimicrobials [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>] but in this study they were not. One explanation for the MDR phenotype and high resistance to non-β-lactam antimicrobials among CA-MRSA could be acquisition of drug resistance genes [<xref ref-type="bibr" rid="CR27">27</xref>]. A similar trend of CA-MRSA being MDR has been observed elsewhere especially in Europe, Asia and the Americas [<xref ref-type="bibr" rid="CR43">43</xref>–<xref ref-type="bibr" rid="CR46">46</xref>]. Case in point is a study from a large veterinary teaching hospital in Costa Rica where nearly all CA-MRSA isolates investigated were MDR and carried SCC<italic>mec</italic> type IV [<xref ref-type="bibr" rid="CR44">44</xref>].</p><p id="Par33">Lastly, this study had a few limitations. First, the small number of MRSA isolates investigated implies that differences observed could be due to low frequencies of genotypes recorded. However, we sampled a larger population for recovery of MRSA compared to previous studies in Uganda [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR22">22</xref>, <xref ref-type="bibr" rid="CR23">23</xref>]. Second, for reasons already explained, we used isolate genotypic characteristics to classify MRSA isolates as our interest was in unambiguously identifying CA-MRSA and HA-MRSA. While important, clinical/epidemiological features were not considered as both CA-MRSA and HA-MRSA may occur in either setting i.e. community or hospital [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR21">21</xref>].</p></sec><sec id="Sec11" sec-type="conclusions"><title>Conclusions</title><p id="Par34">The MRSA carriage rate in children in rural eastern Uganda is high (5.7%) and comparable to estimates for a large urban teaching facility, Mulago National Referral Hospital, located in Uganda’s capital, Kampala. Importantly, HA-MRSA (mainly of <italic>spa</italic> type t037) and CA-MRSA (mainly of <italic>spa</italic> type t064) coexist in community and hospital settings in Uganda with no statistical significance for observed differences in rates. Because interaction between healthcare workers and community members contributes to presence of HA-MRSA in the community, standard hygiene measures should be reinforced to prevent cross-transmission at the IMHDSS. As well, due to the high proportion of MDR-MRSA detected, outpatient treatment of MRSA infections in eastern Uganda might be difficult.</p></sec></body><back><ack><title>Acknowledgements</title><p>We thank the healthy volunteers, children and guardians for accepting to participate in the study. We also thank the staff and management of the Clinical Microbiology and Molecular Biology Laboratories of Makerere University College of Health Sciences for technical assistance.</p></ack><sec sec-type="author-contribution"><title>Authors’ contributions</title><p>DPK conceived the study, analyzed and interpreted the data, and wrote the first draft of the manuscript. ER, KK, and JS recruited the study participants and provided samples from which staphylococci were isolated. BBA, DPK, FB, BM, EK, RM, HB and FKA performed the microbiological procedures and molecular assays. DPK, CFN, and MLJ supervised the study protocol. All authors read and approved the final manuscript.</p></sec><sec><title>Funding</title><p>This work was supported through funding from GlaxoSmithKline (gsk)‘s Trust in Science scheme, and through postdoctoral research support (to DPK) from Carnegie Cooperation (NGAAI&amp;II) through the Directorate of Research and Graduate Training, Makerere University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></sec><sec sec-type="data-availability"><title>Availability of data and materials</title><p>All data generated or analyzed during this study are included in this published article [and its supplementary information files].</p></sec><sec sec-type="ethics-statement"><sec id="FPar1"><title>Ethics approval and consent to participate</title><p id="Par35">This study was approved by the Higher Degrees Research and Ethics Committee of the School of Biomedical Sciences, Makerere University (Approval Numbers SBS194, REC REF 2011–183 &amp; Ref HS 1080). The parent studies obtained assent from parents/guardians on behalf of the children to participate in the study, as well as consent for sample storage and future use of stored samples in further studies. However, participants’ data was excluded from the analyses.</p></sec><sec id="FPar2"><title>Consent for publication</title><p id="Par36">Not applicable.</p></sec><sec id="FPar3" sec-type="COI-statement"><title>Competing interests</title><p id="Par37">The authors declare that they have no competing interests.</p></sec></sec><ref-list id="Bib1"><title>References</title><ref-list><ref id="CR1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>David</surname><given-names>MZ</given-names></name><name><surname>Daum</surname><given-names>RS</given-names></name></person-group><article-title xml:lang="en">Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic</article-title><source>Clin Microbiol Rev</source><year>2010</year><volume>23</volume><issue>3</issue><fpage>616</fpage><lpage>687</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3cXhtFWgtLnN</pub-id><pub-id pub-id-type="doi">10.1128/CMR.00081-09</pub-id><pub-id pub-id-type="pmid">20610826</pub-id><pub-id pub-id-type="pmcid">2901661</pub-id></mixed-citation></ref><ref id="CR2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kong</surname><given-names>Eric F.</given-names></name><name><surname>Johnson</surname><given-names>Jennifer K.</given-names></name><name><surname>Jabra-Rizk</surname><given-names>Mary Ann</given-names></name></person-group><article-title xml:lang="en">Community-Associated Methicillin-Resistant Staphylococcus aureus: An Enemy amidst Us</article-title><source>PLOS Pathogens</source><year>2016</year><volume>12</volume><issue>10</issue><fpage>e1005837</fpage><pub-id pub-id-type="doi">10.1371/journal.ppat.1005837</pub-id><pub-id pub-id-type="pmid">27711163</pub-id><pub-id pub-id-type="pmcid">5053610</pub-id></mixed-citation></ref><ref id="CR3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Herrmann</surname><given-names>M</given-names></name><name><surname>Abdullah</surname><given-names>S</given-names></name><name><surname>Alabi</surname><given-names>A</given-names></name><name><surname>Alonso</surname><given-names>P</given-names></name><name><surname>Friedrich</surname><given-names>AW</given-names></name><name><surname>Fuhr</surname><given-names>G</given-names></name><name><surname>Germann</surname><given-names>A</given-names></name><name><surname>Kern</surname><given-names>WV</given-names></name><name><surname>Kremsner</surname><given-names>PG</given-names></name><name><surname>Mandomando</surname><given-names>I</given-names></name><etal/></person-group><article-title xml:lang="en">Staphylococcal disease in Africa: another neglected 'tropical' disease</article-title><source>Future Microbiol</source><year>2013</year><volume>8</volume><issue>1</issue><fpage>17</fpage><lpage>26</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC38XhvVGms7bK</pub-id><pub-id pub-id-type="doi">10.2217/fmb.12.126</pub-id><pub-id pub-id-type="pmid">23252490</pub-id></mixed-citation></ref><ref id="CR4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schaumburg</surname><given-names>F</given-names></name><name><surname>Alabi</surname><given-names>AS</given-names></name><name><surname>Peters</surname><given-names>G</given-names></name><name><surname>Becker</surname><given-names>K</given-names></name></person-group><article-title xml:lang="en">New epidemiology of Staphylococcus aureus infection in Africa</article-title><source>Clin Microbiol Infect</source><year>2014</year><volume>20</volume><issue>7</issue><fpage>589</fpage><lpage>596</lpage><pub-id pub-id-type="coi">1:STN:280:DC%2BC2cjmtVWqsg%3D%3D</pub-id><pub-id pub-id-type="doi">10.1111/1469-0691.12690</pub-id><pub-id pub-id-type="pmid">24861767</pub-id></mixed-citation></ref><ref id="CR5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jacob</surname><given-names>ST</given-names></name><name><surname>Moore</surname><given-names>CC</given-names></name><name><surname>Banura</surname><given-names>P</given-names></name><name><surname>Pinkerton</surname><given-names>R</given-names></name><name><surname>Meya</surname><given-names>D</given-names></name><name><surname>Opendi</surname><given-names>P</given-names></name><name><surname>Reynolds</surname><given-names>SJ</given-names></name><name><surname>Kenya-Mugisha</surname><given-names>N</given-names></name><name><surname>Mayanja-Kizza</surname><given-names>H</given-names></name><name><surname>Scheld</surname><given-names>WM</given-names></name><etal/></person-group><article-title xml:lang="en">Severe Sepsis in two Ugandan hospitals: a prospective observational study of management and outcomes in a predominantly HIV-1 infected population</article-title><source>PLoS One</source><year>2009</year><volume>4</volume><issue>11</issue><pub-id pub-id-type="doi">10.1371/journal.pone.0007782</pub-id><pub-id pub-id-type="pmid">19907656</pub-id><pub-id pub-id-type="pmcid">2771355</pub-id></mixed-citation></ref><ref id="CR6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mugalu</surname><given-names>J</given-names></name><name><surname>Nakakeeto</surname><given-names>MK</given-names></name><name><surname>Kiguli</surname><given-names>S</given-names></name><name><surname>Kaddu-Mulindwa</surname><given-names>DH</given-names></name></person-group><article-title xml:lang="en">Aetiology, risk factors and immediate outcome of bacteriologically confirmed neonatal septicaemia in Mulago hospital, Uganda</article-title><source>Afr Health Sci</source><year>2006</year><volume>6</volume><issue>2</issue><fpage>120</fpage><lpage>126</lpage><pub-id pub-id-type="coi">1:STN:280:DC%2BD28vpt1Smug%3D%3D</pub-id><pub-id pub-id-type="pmid">16916305</pub-id><pub-id pub-id-type="pmcid">1831983</pub-id></mixed-citation></ref><ref id="CR7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ojulong</surname><given-names>J</given-names></name><name><surname>Mwambu</surname><given-names>T</given-names></name><name><surname>Joloba</surname><given-names>M</given-names></name><name><surname>Bwanga</surname><given-names>F</given-names></name><name><surname>Kaddu-Mulindwa</surname><given-names>D</given-names></name></person-group><article-title xml:lang="en">Relative prevalence of methicilline resistant Staphylococcus aureus and its susceptibility pattern in mulago hospital, Kampala, Uganda</article-title><source>Tanzan J Health Res</source><year>2009</year><volume>11</volume><issue>3</issue><fpage>149</fpage><lpage>153</lpage><pub-id pub-id-type="coi">1:STN:280:DC%2BC3cjnt1emsw%3D%3D</pub-id><pub-id pub-id-type="doi">10.4314/thrb.v11i3.47703</pub-id><pub-id pub-id-type="pmid">20734712</pub-id></mixed-citation></ref><ref id="CR8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seni</surname><given-names>J</given-names></name><name><surname>Najjuka</surname><given-names>CF</given-names></name><name><surname>Kateete</surname><given-names>DP</given-names></name><name><surname>Makobore</surname><given-names>P</given-names></name><name><surname>Joloba</surname><given-names>ML</given-names></name><name><surname>Kajumbula</surname><given-names>H</given-names></name><name><surname>Kapesa</surname><given-names>A</given-names></name><name><surname>Bwanga</surname><given-names>F</given-names></name></person-group><article-title xml:lang="en">Antimicrobial resistance in hospitalized surgical patients: a silently emerging public health concern in Uganda</article-title><source>BMC Res Notes</source><year>2013</year><volume>6</volume><fpage>298</fpage><pub-id pub-id-type="doi">10.1186/1756-0500-6-298</pub-id><pub-id pub-id-type="pmid">23890206</pub-id><pub-id pub-id-type="pmcid">3729663</pub-id></mixed-citation></ref><ref id="CR9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Anguzu</surname><given-names>JR</given-names></name><name><surname>Olila</surname><given-names>D</given-names></name></person-group><article-title xml:lang="en">Drug sensitivity patterns of bacterial isolates from septic post-operative wounds in a regional referral hospital in Uganda</article-title><source>Afr Health Sci</source><year>2007</year><volume>7</volume><issue>3</issue><fpage>148</fpage><lpage>154</lpage><pub-id pub-id-type="coi">1:STN:280:DC%2BD2sjisVeqsg%3D%3D</pub-id><pub-id pub-id-type="pmid">18052868</pub-id><pub-id pub-id-type="pmcid">2269712</pub-id></mixed-citation></ref><ref id="CR10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kizito</surname><given-names>M</given-names></name><name><surname>Mworozi</surname><given-names>E</given-names></name><name><surname>Ndugwa</surname><given-names>C</given-names></name><name><surname>Serjeant</surname><given-names>GR</given-names></name></person-group><article-title xml:lang="en">Bacteraemia in homozygous sickle cell disease in Africa: is pneumococcal prophylaxis justified?</article-title><source>Arch Dis Child</source><year>2007</year><volume>92</volume><issue>1</issue><fpage>21</fpage><lpage>23</lpage><pub-id pub-id-type="coi">1:STN:280:DC%2BD28jks1SgtA%3D%3D</pub-id><pub-id pub-id-type="doi">10.1136/adc.2005.088807</pub-id><pub-id pub-id-type="pmid">16531454</pub-id></mixed-citation></ref><ref id="CR11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bachou</surname><given-names>H</given-names></name><name><surname>Tylleskar</surname><given-names>T</given-names></name><name><surname>Kaddu-Mulindwa</surname><given-names>DH</given-names></name><name><surname>Tumwine</surname><given-names>JK</given-names></name></person-group><article-title xml:lang="en">Bacteraemia among severely malnourished children infected and uninfected with the human immunodeficiency virus-1 in Kampala, Uganda</article-title><source>BMC Infect Dis</source><year>2006</year><volume>6</volume><fpage>160</fpage><pub-id pub-id-type="doi">10.1186/1471-2334-6-160</pub-id><pub-id pub-id-type="pmid">17090299</pub-id><pub-id pub-id-type="pmcid">1660577</pub-id></mixed-citation></ref><ref id="CR12"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Falagas</surname><given-names>ME</given-names></name><name><surname>Karageorgopoulos</surname><given-names>DE</given-names></name><name><surname>Leptidis</surname><given-names>J</given-names></name><name><surname>Korbila</surname><given-names>IP</given-names></name></person-group><article-title xml:lang="en">MRSA in Africa: filling the global map of antimicrobial resistance</article-title><source>PLoS One</source><year>2013</year><volume>8</volume><issue>7</issue><pub-id pub-id-type="doi">10.1371/journal.pone.0068024</pub-id><pub-id pub-id-type="pmid">23922652</pub-id><pub-id pub-id-type="pmcid">3726677</pub-id></mixed-citation></ref><ref id="CR13"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rutebemberwa</surname><given-names>E</given-names></name><name><surname>Mpeka</surname><given-names>B</given-names></name><name><surname>Pariyo</surname><given-names>G</given-names></name><name><surname>Peterson</surname><given-names>S</given-names></name><name><surname>Mworozi</surname><given-names>E</given-names></name><name><surname>Bwanga</surname><given-names>F</given-names></name><name><surname>Källander</surname><given-names>K</given-names></name></person-group><article-title xml:lang="en">High prevalence of antibiotic resistance in nasopharyngeal bacterial isolates from healthy children in rural Uganda: a cross-sectional study</article-title><source>Ups J Med Sci</source><year>2015</year><volume>120</volume><issue>4</issue><fpage>249</fpage><lpage>256</lpage><pub-id pub-id-type="doi">10.3109/03009734.2015.1072606</pub-id><pub-id pub-id-type="pmid">26305429</pub-id><pub-id pub-id-type="pmcid">4816885</pub-id></mixed-citation></ref><ref id="CR14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choo</surname><given-names>EJ</given-names></name></person-group><article-title xml:lang="en">Community-associated methicillin-resistant Staphylococcus aureus in nosocomial infections</article-title><source>Infect Chemother</source><year>2017</year><volume>49</volume><issue>2</issue><fpage>158</fpage><lpage>159</lpage><pub-id pub-id-type="doi">10.3947/ic.2017.49.2.158</pub-id><pub-id pub-id-type="pmid">28681579</pub-id><pub-id pub-id-type="pmcid">5500275</pub-id></mixed-citation></ref><ref id="CR15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdulgader</surname><given-names>SM</given-names></name><name><surname>Shittu</surname><given-names>AO</given-names></name><name><surname>Nicol</surname><given-names>MP</given-names></name><name><surname>Kaba</surname><given-names>M</given-names></name></person-group><article-title xml:lang="en">Molecular epidemiology of methicillin-resistant Staphylococcus aureus in Africa: a systematic review</article-title><source>Front Microbiol</source><year>2015</year><volume>6</volume><fpage>348</fpage><pub-id pub-id-type="doi">10.3389/fmicb.2015.00348</pub-id><pub-id pub-id-type="pmid">25983721</pub-id><pub-id pub-id-type="pmcid">4415431</pub-id></mixed-citation></ref><ref id="CR16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hudson</surname><given-names>LO</given-names></name><name><surname>Murphy</surname><given-names>CR</given-names></name><name><surname>Spratt</surname><given-names>BG</given-names></name><name><surname>Enright</surname><given-names>MC</given-names></name><name><surname>Terpstra</surname><given-names>L</given-names></name><name><surname>Gombosev</surname><given-names>A</given-names></name><name><surname>Hannah</surname><given-names>P</given-names></name><name><surname>Mikhail</surname><given-names>L</given-names></name><name><surname>Alexander</surname><given-names>R</given-names></name><name><surname>Moore</surname><given-names>DF</given-names></name></person-group><article-title xml:lang="en">Differences in methicillin-resistant Staphylococcus aureus strains isolated from pediatric and adult patients from hospitals in a large county in California</article-title><source>J Clin Microbiol</source><year>2012</year><volume>50</volume><issue>3</issue><fpage>573</fpage><lpage>579</lpage><pub-id pub-id-type="doi">10.1128/JCM.05336-11</pub-id><pub-id pub-id-type="pmid">22205805</pub-id><pub-id pub-id-type="pmcid">3295185</pub-id></mixed-citation></ref><ref id="CR17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Prosperi</surname><given-names>M</given-names></name><name><surname>Veras</surname><given-names>N</given-names></name><name><surname>Azarian</surname><given-names>T</given-names></name><name><surname>Rathore</surname><given-names>M</given-names></name><name><surname>Nolan</surname><given-names>D</given-names></name><name><surname>Rand</surname><given-names>K</given-names></name><name><surname>Cook</surname><given-names>RL</given-names></name><name><surname>Johnson</surname><given-names>J</given-names></name><name><surname>Morris</surname><given-names>JG</given-names><suffix>Jr</suffix></name><name><surname>Salemi</surname><given-names>M</given-names></name></person-group><article-title xml:lang="en">Molecular epidemiology of community-associated methicillin-resistant Staphylococcus aureus in the genomic era: a cross-sectional study</article-title><source>Sci Rep</source><year>2013</year><volume>3</volume><fpage>1902</fpage><pub-id pub-id-type="doi">10.1038/srep01902</pub-id><pub-id pub-id-type="pmid">23712667</pub-id><pub-id pub-id-type="pmcid">3664956</pub-id></mixed-citation></ref><ref id="CR18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monecke</surname><given-names>S</given-names></name><name><surname>Coombs</surname><given-names>G</given-names></name><name><surname>Shore</surname><given-names>AC</given-names></name><name><surname>Coleman</surname><given-names>DC</given-names></name><name><surname>Akpaka</surname><given-names>P</given-names></name><name><surname>Borg</surname><given-names>M</given-names></name><name><surname>Chow</surname><given-names>H</given-names></name><name><surname>Ip</surname><given-names>M</given-names></name><name><surname>Jatzwauk</surname><given-names>L</given-names></name><name><surname>Jonas</surname><given-names>D</given-names></name><etal/></person-group><article-title xml:lang="en">A field guide to pandemic, epidemic and sporadic clones of methicillin-resistant Staphylococcus aureus</article-title><source>PLoS One</source><year>2011</year><volume>6</volume><issue>4</issue><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3MXltVWmu74%3D</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0017936</pub-id><pub-id pub-id-type="pmid">21494333</pub-id><pub-id pub-id-type="pmcid">21494333</pub-id></mixed-citation></ref><ref id="CR19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>David</surname><given-names>MZ</given-names></name><name><surname>Cadilla</surname><given-names>A</given-names></name><name><surname>Boyle-Vavra</surname><given-names>S</given-names></name><name><surname>Daum</surname><given-names>RS</given-names></name></person-group><article-title xml:lang="en">Replacement of HA-MRSA by CA-MRSA infections at an academic medical center in the midwestern United States, 2004-5 to 2008</article-title><source>PLoS One</source><year>2014</year><volume>9</volume><issue>4</issue><fpage>e92760</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0092760</pub-id><pub-id pub-id-type="pmid">24755631</pub-id><pub-id pub-id-type="pmcid">24755631</pub-id></mixed-citation></ref><ref id="CR20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nimmo</surname><given-names>GR</given-names></name><name><surname>Coombs</surname><given-names>GW</given-names></name></person-group><article-title xml:lang="en">Community-associated methicillin-resistant Staphylococcus aureus (MRSA) in Australia</article-title><source>Int J Antimicrob Agents</source><year>2008</year><volume>31</volume><issue>5</issue><fpage>401</fpage><lpage>410</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD1cXkvVOksbY%3D</pub-id><pub-id pub-id-type="doi">10.1016/j.ijantimicag.2007.08.011</pub-id><pub-id pub-id-type="pmid">18342492</pub-id></mixed-citation></ref><ref id="CR21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kouyos</surname><given-names>R</given-names></name><name><surname>Klein</surname><given-names>E</given-names></name><name><surname>Grenfell</surname><given-names>B</given-names></name></person-group><article-title xml:lang="en">Hospital-community interactions Foster coexistence between methicillin-resistant strains of Staphylococcus aureus</article-title><source>PLoS Pathog</source><year>2013</year><volume>9</volume><issue>2</issue><pub-id pub-id-type="doi">10.1371/journal.ppat.1003134</pub-id><pub-id pub-id-type="pmid">23468619</pub-id><pub-id pub-id-type="pmcid">3585153</pub-id></mixed-citation></ref><ref id="CR22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kateete</surname><given-names>DP</given-names></name><name><surname>Namazzi</surname><given-names>S</given-names></name><name><surname>Okee</surname><given-names>M</given-names></name><name><surname>Okeng</surname><given-names>A</given-names></name><name><surname>Baluku</surname><given-names>H</given-names></name><name><surname>Musisi</surname><given-names>NL</given-names></name><name><surname>Katabazi</surname><given-names>FA</given-names></name><name><surname>Joloba</surname><given-names>ML</given-names></name><name><surname>Ssentongo</surname><given-names>R</given-names></name><name><surname>Najjuka</surname><given-names>FC</given-names></name></person-group><article-title xml:lang="en">High prevalence of methicillin resistant Staphylococcus aureus in the surgical units of Mulago hospital in Kampala, Uganda</article-title><source>BMC Res Notes</source><year>2011</year><volume>4</volume><fpage>326</fpage><pub-id pub-id-type="doi">10.1186/1756-0500-4-326</pub-id><pub-id pub-id-type="pmid">21899769</pub-id><pub-id pub-id-type="pmcid">3184088</pub-id></mixed-citation></ref><ref id="CR23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Seni</surname><given-names>J</given-names></name><name><surname>Bwanga</surname><given-names>F</given-names></name><name><surname>Najjuka</surname><given-names>CF</given-names></name><name><surname>Makobore</surname><given-names>P</given-names></name><name><surname>Okee</surname><given-names>M</given-names></name><name><surname>Mshana</surname><given-names>SE</given-names></name><name><surname>Kidenya</surname><given-names>BR</given-names></name><name><surname>Joloba</surname><given-names>ML</given-names></name><name><surname>Kateete</surname><given-names>DP</given-names></name></person-group><article-title xml:lang="en">Molecular characterization of Staphylococcus aureus from patients with surgical site infections at Mulago Hospital in Kampala, Uganda</article-title><source>PloS one</source><year>2013</year><volume>8</volume><issue>6</issue><fpage>e66153</fpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3sXhtVKltbfO</pub-id><pub-id pub-id-type="doi">10.1371/journal.pone.0066153</pub-id><pub-id pub-id-type="pmid">23840416</pub-id><pub-id pub-id-type="pmcid">3688721</pub-id></mixed-citation></ref><ref id="CR24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kalyango</surname><given-names>JN</given-names></name><name><surname>Alfven</surname><given-names>T</given-names></name><name><surname>Peterson</surname><given-names>S</given-names></name><name><surname>Mugenyi</surname><given-names>K</given-names></name><name><surname>Karamagi</surname><given-names>C</given-names></name><name><surname>Rutebemberwa</surname><given-names>E</given-names></name></person-group><article-title xml:lang="en">Integrated community case management of malaria and pneumonia increases prompt and appropriate treatment for pneumonia symptoms in children under five years in eastern Uganda</article-title><source>Malar J</source><year>2013</year><volume>12</volume><fpage>340</fpage><pub-id pub-id-type="doi">10.1186/1475-2875-12-340</pub-id><pub-id pub-id-type="pmid">24053172</pub-id><pub-id pub-id-type="pmcid">3848942</pub-id></mixed-citation></ref><ref id="CR25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kateete</surname><given-names>DP</given-names></name><name><surname>Kimani</surname><given-names>CN</given-names></name><name><surname>Katabazi</surname><given-names>FA</given-names></name><name><surname>Okeng</surname><given-names>A</given-names></name><name><surname>Okee</surname><given-names>MS</given-names></name><name><surname>Nanteza</surname><given-names>A</given-names></name><name><surname>Joloba</surname><given-names>ML</given-names></name><name><surname>Najjuka</surname><given-names>FC</given-names></name></person-group><article-title xml:lang="en">Identification of Staphylococcus aureus: DNase and mannitol salt agar improve the efficiency of the tube coagulase test</article-title><source>Ann Clin Microbiol Antimicrob</source><year>2010</year><volume>9</volume><fpage>23</fpage><pub-id pub-id-type="doi">10.1186/1476-0711-9-23</pub-id><pub-id pub-id-type="pmid">20707914</pub-id><pub-id pub-id-type="pmcid">2927478</pub-id></mixed-citation></ref><ref id="CR26"><label>26.</label><mixed-citation publication-type="other">CLSI C: Performance standards for antimicrobial susceptibility testing. <italic>Clinical and Laboratory Standards Institute (M100eS22)</italic> 2012 (s22nd Informational Supplement).</mixed-citation></ref><ref id="CR27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nimmo</surname><given-names>GR</given-names></name><name><surname>Bergh</surname><given-names>H</given-names></name><name><surname>Nakos</surname><given-names>J</given-names></name><name><surname>Whiley</surname><given-names>D</given-names></name><name><surname>Marquess</surname><given-names>J</given-names></name><name><surname>Huygens</surname><given-names>F</given-names></name><name><surname>Paterson</surname><given-names>DL</given-names></name></person-group><article-title xml:lang="en">Replacement of healthcare-associated MRSA by community-associated MRSA in Queensland: confirmation by genotyping</article-title><source>J Infect</source><year>2013</year><volume>67</volume><issue>5</issue><fpage>439</fpage><lpage>447</lpage><pub-id pub-id-type="doi">10.1016/j.jinf.2013.07.020</pub-id><pub-id pub-id-type="pmid">23872210</pub-id></mixed-citation></ref><ref id="CR28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coombs</surname><given-names>GW</given-names></name><name><surname>Daley</surname><given-names>DA</given-names></name><name><surname>Lee</surname><given-names>YT</given-names></name><name><surname>Pang</surname><given-names>S</given-names></name><name><surname>Bell</surname><given-names>JM</given-names></name><name><surname>Turnidge</surname><given-names>JD</given-names></name></person-group><article-title xml:lang="en">Australian group on antimicrobial resistance (AGAR) Australian Staphylococcus aureus Sepsis outcome Programme (ASSOP) annual report 2015</article-title><source>Commun Dis Intell</source><year>2018</year><volume>2018</volume><fpage>42</fpage></mixed-citation></ref><ref id="CR29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boye</surname><given-names>K</given-names></name><name><surname>Bartels</surname><given-names>MD</given-names></name><name><surname>Andersen</surname><given-names>IS</given-names></name><name><surname>Moller</surname><given-names>JA</given-names></name><name><surname>Westh</surname><given-names>H</given-names></name></person-group><article-title xml:lang="en">A new multiplex PCR for easy screening of methicillin-resistant Staphylococcus aureus SCCmec types I-V</article-title><source>Clin Microbiol Infect</source><year>2007</year><volume>13</volume><issue>7</issue><fpage>725</fpage><lpage>727</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2sXotlSht7o%3D</pub-id><pub-id pub-id-type="doi">10.1111/j.1469-0691.2007.01720.x</pub-id><pub-id pub-id-type="pmid">17403127</pub-id></mixed-citation></ref><ref id="CR30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asiimwe</surname><given-names>BB</given-names></name><name><surname>Baldan</surname><given-names>R</given-names></name><name><surname>Trovato</surname><given-names>A</given-names></name><name><surname>Cirillo</surname><given-names>DM</given-names></name></person-group><article-title xml:lang="en">Prevalence and molecular characteristics of Staphylococcus aureus, including methicillin resistant strains, isolated from bulk can milk and raw milk products in pastoral communities of south-West Uganda</article-title><source>BMC Infect Dis</source><year>2017</year><volume>17</volume><issue>1</issue><fpage>422</fpage><pub-id pub-id-type="doi">10.1186/s12879-017-2524-4</pub-id><pub-id pub-id-type="pmid">28610560</pub-id><pub-id pub-id-type="pmcid">5470224</pub-id></mixed-citation></ref><ref id="CR31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Asiimwe</surname><given-names>BB</given-names></name><name><surname>Baldan</surname><given-names>R</given-names></name><name><surname>Trovato</surname><given-names>A</given-names></name><name><surname>Cirillo</surname><given-names>DM</given-names></name></person-group><article-title xml:lang="en">Molecular epidemiology of Panton-valentine Leukocidin-positive community-acquired methicillin resistant Staphylococcus aureus isolates in pastoral communities of rural south western Uganda</article-title><source>BMC Infect Dis</source><year>2017</year><volume>17</volume><fpage>24</fpage><pub-id pub-id-type="doi">10.1186/s12879-016-2124-8</pub-id><pub-id pub-id-type="pmid">28056833</pub-id><pub-id pub-id-type="pmcid">5216539</pub-id></mixed-citation></ref><ref id="CR32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harmsen</surname><given-names>D</given-names></name><name><surname>Claus</surname><given-names>H</given-names></name><name><surname>Witte</surname><given-names>W</given-names></name><name><surname>Rothganger</surname><given-names>J</given-names></name><name><surname>Turnwald</surname><given-names>D</given-names></name><name><surname>Vogel</surname><given-names>U</given-names></name></person-group><article-title xml:lang="en">Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management</article-title><source>J Clin Microbiol</source><year>2003</year><volume>41</volume><issue>12</issue><fpage>5442</fpage><lpage>5448</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BD2cXjtFyqtA%3D%3D</pub-id><pub-id pub-id-type="doi">10.1128/JCM.41.12.5442-5448.2003</pub-id><pub-id pub-id-type="pmid">14662923</pub-id><pub-id pub-id-type="pmcid">309029</pub-id></mixed-citation></ref><ref id="CR33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Joachim</surname><given-names>A</given-names></name><name><surname>Moyo</surname><given-names>SJ</given-names></name><name><surname>Nkinda</surname><given-names>L</given-names></name><name><surname>Majigo</surname><given-names>M</given-names></name><name><surname>Mmbaga</surname><given-names>E</given-names></name><name><surname>Mbembati</surname><given-names>N</given-names></name><name><surname>Aboud</surname><given-names>S</given-names></name><name><surname>Lyamuya</surname><given-names>EF</given-names></name></person-group><article-title xml:lang="en">Prevalence of methicillin-resistant Staphylococcus aureus carriage on admission among patients attending regional hospitals in Dar Es Salaam, Tanzania</article-title><source>BMC Res Notes</source><year>2017</year><volume>10</volume><issue>1</issue><fpage>417</fpage><pub-id pub-id-type="doi">10.1186/s13104-017-2668-8</pub-id><pub-id pub-id-type="pmid">28830510</pub-id><pub-id pub-id-type="pmcid">5568238</pub-id></mixed-citation></ref><ref id="CR34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Aiken</surname><given-names>AM</given-names></name><name><surname>Mutuku</surname><given-names>IM</given-names></name><name><surname>Sabat</surname><given-names>AJ</given-names></name><name><surname>Akkerboom</surname><given-names>V</given-names></name><name><surname>Mwangi</surname><given-names>J</given-names></name><name><surname>Scott</surname><given-names>JAG</given-names></name><name><surname>Morpeth</surname><given-names>SC</given-names></name><name><surname>Friedrich</surname><given-names>AW</given-names></name><name><surname>Grundmann</surname><given-names>H</given-names></name></person-group><article-title xml:lang="en">Carriage of Staphylococcus aureus in Thika level 5 hospital, Kenya: a cross-sectional study</article-title><source>Antimicrob Resist Infect Control</source><year>2014</year><volume>3</volume><fpage>22</fpage><pub-id pub-id-type="doi">10.1186/2047-2994-3-22</pub-id><pub-id pub-id-type="pmid">25057351</pub-id><pub-id pub-id-type="pmcid">4107749</pub-id></mixed-citation></ref><ref id="CR35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>Q</given-names></name><name><surname>Cheng</surname><given-names>H</given-names></name><name><surname>Yuan</surname><given-names>W</given-names></name><name><surname>Zeng</surname><given-names>F</given-names></name><name><surname>Shang</surname><given-names>W</given-names></name><name><surname>Tang</surname><given-names>D</given-names></name><name><surname>Xue</surname><given-names>W</given-names></name><name><surname>Fu</surname><given-names>J</given-names></name><name><surname>Zhou</surname><given-names>R</given-names></name><name><surname>Zhu</surname><given-names>J</given-names></name><etal/></person-group><article-title xml:lang="en">Panton-valentine leukocidin (PVL)-positive health care-associated methicillin-resistant Staphylococcus aureus isolates are associated with skin and soft tissue infections and colonized mainly by infective PVL-encoding bacteriophages</article-title><source>J Clin Microbiol</source><year>2015</year><volume>53</volume><issue>1</issue><fpage>67</fpage><lpage>72</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2MXptl2lsg%3D%3D</pub-id><pub-id pub-id-type="doi">10.1128/JCM.01722-14</pub-id><pub-id pub-id-type="pmid">25339405</pub-id></mixed-citation></ref><ref id="CR36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>TM</given-names></name><name><surname>Yang</surname><given-names>MC</given-names></name><name><surname>Yang</surname><given-names>TF</given-names></name><name><surname>Lee</surname><given-names>PL</given-names></name><name><surname>Chien</surname><given-names>HI</given-names></name><name><surname>Hsueh</surname><given-names>JC</given-names></name><name><surname>Chang</surname><given-names>SH</given-names></name><name><surname>Hsu</surname><given-names>CH</given-names></name><name><surname>Chien</surname><given-names>ST</given-names></name></person-group><article-title xml:lang="en">Molecular Characterization of Community- and Healthcare-Associated Methicillin-Resistant <italic>Staphylococcus aureus</italic> Isolates in Southern Taiwan</article-title><source>Microb Drug Resist (Larchmont, NY)</source><year>2015</year><volume>21</volume><issue>6</issue><fpage>610</fpage><lpage>621</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC2MXhvFOrtbbE</pub-id><pub-id pub-id-type="doi">10.1089/mdr.2015.0020</pub-id></mixed-citation></ref><ref id="CR37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miura</surname><given-names>Y</given-names></name><name><surname>Yamaguchi</surname><given-names>T</given-names></name><name><surname>Nakamura</surname><given-names>I</given-names></name><name><surname>Koyama</surname><given-names>S</given-names></name><name><surname>Tamai</surname><given-names>K</given-names></name><name><surname>Okanda</surname><given-names>T</given-names></name><name><surname>Matsumoto</surname><given-names>T</given-names></name></person-group><article-title xml:lang="en">Epidemiological trends observed from molecular characterization of methicillin-resistant Staphylococcus aureus isolates from blood cultures at a Japanese University hospital<bold>,</bold> 2012-2015</article-title><source>Microbial Drug Resis (Larchmont, NY)</source><year>2018</year><volume>24</volume><issue>1</issue><fpage>70</fpage><lpage>75</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC1cXmt1eqtQ%3D%3D</pub-id><pub-id pub-id-type="doi">10.1089/mdr.2017.0008</pub-id></mixed-citation></ref><ref id="CR38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tenover</surname><given-names>FC</given-names></name><name><surname>Tickler</surname><given-names>IA</given-names></name><name><surname>Goering</surname><given-names>RV</given-names></name><name><surname>Kreiswirth</surname><given-names>BN</given-names></name><name><surname>Mediavilla</surname><given-names>JR</given-names></name><name><surname>Persing</surname><given-names>DH</given-names></name></person-group><article-title xml:lang="en">Characterization of nasal and blood culture isolates of methicillin-resistant Staphylococcus aureus from patients in United States hospitals</article-title><source>Antimicrob Agents Chemother</source><year>2012</year><volume>56</volume><issue>3</issue><fpage>1324</fpage><lpage>1330</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC38XjsVKlsLk%3D</pub-id><pub-id pub-id-type="doi">10.1128/AAC.05804-11</pub-id><pub-id pub-id-type="pmid">22155818</pub-id><pub-id pub-id-type="pmcid">3294931</pub-id></mixed-citation></ref><ref id="CR39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Egyir</surname><given-names>B</given-names></name><name><surname>Guardabassi</surname><given-names>L</given-names></name><name><surname>Sørum</surname><given-names>M</given-names></name><name><surname>Nielsen</surname><given-names>SS</given-names></name><name><surname>Kolekang</surname><given-names>A</given-names></name><name><surname>Frimpong</surname><given-names>E</given-names></name><name><surname>Addo</surname><given-names>KK</given-names></name><name><surname>Newman</surname><given-names>MJ</given-names></name><name><surname>Larsen</surname><given-names>AR</given-names></name></person-group><article-title xml:lang="en">Molecular epidemiology and antimicrobial susceptibility of clinical Staphylococcus aureus from healthcare institutions in Ghana</article-title><source>PLoS One</source><year>2014</year><volume>9</volume><issue>2</issue><pub-id pub-id-type="doi">10.1371/journal.pone.0089716</pub-id><pub-id pub-id-type="pmid">24586981</pub-id><pub-id pub-id-type="pmcid">3934920</pub-id></mixed-citation></ref><ref id="CR40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moodley</surname><given-names>A</given-names></name><name><surname>Oosthuysen</surname><given-names>WF</given-names></name><name><surname>Dusé</surname><given-names>AG</given-names></name><name><surname>Marais</surname><given-names>E</given-names></name></person-group><article-title xml:lang="en">Molecular characterization of clinical methicillin-resistant &lt;em&gt;Staphylococcus aureus&lt;/em&gt; isolates in South Africa</article-title><source>J Clin Microbiol</source><year>2010</year><volume>48</volume><issue>12</issue><fpage>4608</fpage><lpage>4611</lpage><pub-id pub-id-type="coi">1:STN:280:DC%2BC3M%2Fgt1KhsQ%3D%3D</pub-id><pub-id pub-id-type="doi">10.1128/JCM.01704-10</pub-id><pub-id pub-id-type="pmid">20881169</pub-id><pub-id pub-id-type="pmcid">3008489</pub-id></mixed-citation></ref><ref id="CR41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shittu</surname><given-names>A</given-names></name><name><surname>Oyedara</surname><given-names>O</given-names></name><name><surname>Abegunrin</surname><given-names>F</given-names></name><name><surname>Okon</surname><given-names>K</given-names></name><name><surname>Raji</surname><given-names>A</given-names></name><name><surname>Taiwo</surname><given-names>S</given-names></name><name><surname>Ogunsola</surname><given-names>F</given-names></name><name><surname>Onyedibe</surname><given-names>K</given-names></name><name><surname>Elisha</surname><given-names>G</given-names></name></person-group><article-title xml:lang="en">Characterization of methicillin-susceptible and -resistant staphylococci in the clinical setting: a multicentre study in Nigeria</article-title><source>BMC Infect Dis</source><year>2012</year><volume>12</volume><issue>1</issue><fpage>286</fpage><pub-id pub-id-type="doi">10.1186/1471-2334-12-286</pub-id><pub-id pub-id-type="pmid">23121720</pub-id><pub-id pub-id-type="pmcid">3529121</pub-id></mixed-citation></ref><ref id="CR42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shittu</surname><given-names>AO</given-names></name><name><surname>Okon</surname><given-names>K</given-names></name><name><surname>Adesida</surname><given-names>S</given-names></name><name><surname>Oyedara</surname><given-names>O</given-names></name><name><surname>Witte</surname><given-names>W</given-names></name><name><surname>Strommenger</surname><given-names>B</given-names></name><name><surname>Layer</surname><given-names>F</given-names></name><name><surname>Nübel</surname><given-names>U</given-names></name></person-group><article-title xml:lang="en">Antibiotic resistance and molecular epidemiology of Staphylococcus aureus in Nigeria</article-title><source>BMC Microbiol</source><year>2011</year><volume>11</volume><issue>1</issue><fpage>92</fpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC3MXmt1Oms7g%3D</pub-id><pub-id pub-id-type="doi">10.1186/1471-2180-11-92</pub-id><pub-id pub-id-type="pmid">21545717</pub-id><pub-id pub-id-type="pmcid">3112067</pub-id></mixed-citation></ref><ref id="CR43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Earls</surname><given-names>MR</given-names></name><name><surname>Kinnevey</surname><given-names>PM</given-names></name><name><surname>Brennan</surname><given-names>GI</given-names></name><name><surname>Lazaris</surname><given-names>A</given-names></name><name><surname>Skally</surname><given-names>M</given-names></name><name><surname>O’Connell</surname><given-names>B</given-names></name><name><surname>Humphreys</surname><given-names>H</given-names></name><name><surname>Shore</surname><given-names>AC</given-names></name><name><surname>Coleman</surname><given-names>DC</given-names></name></person-group><article-title xml:lang="en">The recent emergence in hospitals of multidrug-resistant community-associated sequence type 1 and spa type t127 methicillin-resistant Staphylococcus aureus investigated by whole-genome sequencing: implications for screening</article-title><source>PLoS One</source><year>2017</year><volume>12</volume><issue>4</issue><pub-id pub-id-type="doi">10.1371/journal.pone.0175542</pub-id><pub-id pub-id-type="pmid">28399151</pub-id><pub-id pub-id-type="pmcid">5388477</pub-id></mixed-citation></ref><ref id="CR44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rojas</surname><given-names>I</given-names></name><name><surname>Barquero-Calvo</surname><given-names>E</given-names></name><name><surname>van Balen</surname><given-names>JC</given-names></name><name><surname>Rojas</surname><given-names>N</given-names></name><name><surname>Muñoz-Vargas</surname><given-names>L</given-names></name><name><surname>Hoet</surname><given-names>AE</given-names></name></person-group><article-title xml:lang="en">High Prevalence of Multidrug-Resistant Community-Acquired Methicillin-Resistant <italic>Staphylococcus aureus</italic> at the Largest Veterinary Teaching Hospital in Costa Rica</article-title><source>Vector Borne Zoonotic Dis (Larchmont, NY)</source><year>2017</year><volume>17</volume><issue>9</issue><fpage>645</fpage><lpage>653</lpage><pub-id pub-id-type="doi">10.1089/vbz.2017.2145</pub-id></mixed-citation></ref><ref id="CR45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Liu</surname><given-names>Y</given-names></name><name><surname>Yang</surname><given-names>Y</given-names></name><name><surname>Huang</surname><given-names>G</given-names></name><name><surname>Wang</surname><given-names>C</given-names></name><name><surname>Deng</surname><given-names>L</given-names></name><name><surname>Zheng</surname><given-names>Y</given-names></name><name><surname>Fu</surname><given-names>Z</given-names></name><name><surname>Li</surname><given-names>C</given-names></name><name><surname>Shang</surname><given-names>Y</given-names></name><etal/></person-group><article-title xml:lang="en">Multidrug-resistant clones of community-associated meticillin-resistant Staphylococcus aureus isolated from Chinese children and the resistance genes to clindamycin and mupirocin</article-title><source>J Med Microbiol</source><year>2012</year><volume>61</volume><issue>Pt 9</issue><fpage>1240</fpage><lpage>1247</lpage><pub-id pub-id-type="coi">1:CAS:528:DC%2BC38Xhs1WnsbbI</pub-id><pub-id pub-id-type="doi">10.1099/jmm.0.042663-0</pub-id><pub-id pub-id-type="pmid">22595913</pub-id></mixed-citation></ref><ref id="CR46"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wilson</surname><given-names>J</given-names></name><name><surname>Lawson</surname><given-names>KA</given-names></name><name><surname>Frei</surname><given-names>CR</given-names></name><name><surname>Lee</surname><given-names>GC</given-names></name><name><surname>Dallas</surname><given-names>SD</given-names></name><name><surname>Wang</surname><given-names>Y</given-names></name><name><surname>Olsen</surname><given-names>RJ</given-names></name></person-group><article-title xml:lang="en">Emerging multidrug resistance in community-associated Staphylococcus aureus involved in skin and soft tissue infections and nasal colonization</article-title><source>J Antimicrob Chemother</source><year>2017</year><volume>72</volume><issue>9</issue><fpage>2461</fpage><lpage>2468</lpage><pub-id pub-id-type="doi">10.1093/jac/dkx181</pub-id><pub-id pub-id-type="pmid">28859442</pub-id><pub-id pub-id-type="pmcid">5890715</pub-id></mixed-citation></ref></ref-list></ref-list><app-group><app id="App1"><sec id="Sec12"><title>Additional file</title><p id="Par38"><supplementary-material content-type="local-data" id="MOESM1" xlink:title="Additional file"><media xlink:href="MediaObjects/13756_2019_551_MOESM1_ESM.tiff" mimetype="image" mime-subtype="tiff"><caption xml:lang="en"><p><bold>Figure S1.</bold><italic>Spa</italic> types for MRSA isolates from children under 5 years in rural eastern Uganda. MH denotes Mulago National Referral Hospital; IMHDSS, Health &amp; Demographic Surveillance Site; RWU, Rural Western Uganda. The circle signifies <italic>spa</italic> types that appear restricted to rural western Uganda. (TIFF 3173 kb)</p></caption></media></supplementary-material></p></sec></app></app-group><glossary><title>Abbreviations</title><def-list><def-item><term>CTAB</term><def><p id="Par5">Cetrimonium bromide</p></def></def-item><def-item><term>IMHDSS</term><def><p id="Par6">Iganga-Mayuge Health &amp; Demographic Surveillance Site</p></def></def-item><def-item><term><italic>mecA</italic></term><def><p id="Par7">Gene encoding the penicillin binding protein 2a (PBP2a)</p></def></def-item><def-item><term>MIC</term><def><p id="Par8">Minimum inhibitory concentration</p></def></def-item><def-item><term>MRSA</term><def><p id="Par9">Methicillin resistant <italic>Staphylococcus aureus</italic></p></def></def-item><def-item><term>MSSA</term><def><p id="Par10">Methicillin Susceptible <italic>Staphylococcus aureus</italic></p></def></def-item><def-item><term>PCR</term><def><p id="Par11">Polymerase chain reaction</p></def></def-item><def-item><term>PVL</term><def><p id="Par12">Panton Valentine leukocidin</p></def></def-item><def-item><term>SCC<italic>mec</italic></term><def><p id="Par13">Staphylococcal cassette chromosome mec</p></def></def-item><def-item><term>Spa</term><def><p id="Par14">Staphylococcal protein A</p></def></def-item><def-item><term>SXT</term><def><p id="Par15">Trimethoprim/sulfamethoxazole</p></def></def-item></def-list></glossary><notes notes-type="Misc"><title>Publisher’s Note</title><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></notes></back></article></records><facets><facet name="subject"><facet-value count="1">Biomedicine</facet-value><facet-value count="1">Drug Resistance</facet-value><facet-value count="1">Infectious Diseases</facet-value><facet-value count="1">Medical Microbiology</facet-value></facet><facet name="keyword"><facet-value count="1">
                        spa types</facet-value><facet-value count="1">
                mecA
              </facet-value><facet-value count="1">Coexistence</facet-value><facet-value count="1">Community-associated MRSA</facet-value><facet-value count="1">Eastern Uganda</facet-value><facet-value count="1">Hospital-associated MRSA</facet-value><facet-value count="1">Iganga/Mayuge districts</facet-value><facet-value count="1">SCCmec types</facet-value></facet><facet name="pub"><facet-value count="1">Antimicrobial Resistance &amp; Infection Control</facet-value></facet><facet name="year"><facet-value count="1">2019</facet-value></facet><facet name="country"><facet-value count="1">Sweden</facet-value><facet-value count="1">Tanzania</facet-value><facet-value count="1">Uganda</facet-value><facet-value count="1">United Kingdom</facet-value></facet><facet name="type"><facet-value count="1">Journal</facet-value></facet></facets></response>
